Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 39 | 37 | −2 |
| Shares | 24.0M | 22.6M | −1.38M (−5.7%) |
| Value | $33.6M | $17.0M | −$16.6M (−49.5%) |
New holders (4)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 41,528 | $31.1K | 0.00% |
| Assenagon Asset Management S.A. | 34,488 | $25.9K | 0.00% |
| Susquehanna International Group, LLP | 22,410 | $16.8K | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,000 | $750 | 0.00% |
Sold out (6)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| OrbiMed Advisors LLC | 1,541,000 | $2.16M |
| Squarepoint Ops LLC | 78,020 | $109.2K |
| Millennium Management LLC | 45,956 | $64.3K |
| XTX Topco Ltd | 12,826 | $18.0K |
| Virtu Financial LLC | 10,938 | $15.0K |
| Wells Fargo & Company | 211 | $295 |